0000899243-19-026147.txt : 20191029
0000899243-19-026147.hdr.sgml : 20191029
20191029203145
ACCESSION NUMBER: 0000899243-19-026147
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180502
FILED AS OF DATE: 20191029
DATE AS OF CHANGE: 20191029
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lee June
CENTRAL INDEX KEY: 0001696493
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37609
FILM NUMBER: 191177134
MAIL ADDRESS:
STREET 1: C/O MYOKARDIA, INC.
STREET 2: 333 ALLERTON AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MyoKardia Inc
CENTRAL INDEX KEY: 0001552451
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 455500552
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-741-0900
MAIL ADDRESS:
STREET 1: 333 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-05-02
1
0001552451
MyoKardia Inc
MYOK
0001696493
Lee June
C/O MYOKARDIA, INC.
333 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
EVP, Chief Development Officer
Common Stock
2018-05-02
4
M
0
5457
11.95
A
9610
D
Common Stock
2018-05-09
4
M
0
4500
11.95
A
14110
D
Common Stock
2018-05-31
4
M
0
364
11.95
A
14474
D
Common Stock
2018-07-10
4
M
0
364
11.95
A
14838
D
Common Stock
2018-08-09
4
M
0
363
11.95
A
15201
D
Common Stock
2018-09-04
4
M
0
364
11.95
A
15565
D
Common Stock
2018-10-01
4
M
0
364
11.95
A
15929
D
Common Stock
2018-10-11
4
M
0
2500
11.95
A
18429
D
Common Stock
2018-11-06
4
M
0
364
11.95
A
18793
D
Common Stock
2018-12-03
4
M
0
364
11.95
A
19157
D
Common Stock
2019-02-25
4
M
0
3000
11.95
A
22157
D
Stock Option (Right to Buy)
11.95
2018-05-02
4
M
0
5457
0.00
D
2027-01-31
Common Stock
5457
110160
D
Stock Option (Right to Buy)
11.95
2018-05-09
4
M
0
4500
0.00
D
2027-01-31
Common Stock
4500
105660
D
Stock Option (Right to Buy)
11.95
2018-05-31
4
M
0
364
0.00
D
2027-01-31
Common Stock
364
105296
D
Stock Option (Right to Buy)
11.95
2018-07-10
4
M
0
364
0.00
D
2027-01-31
Common Stock
364
104932
D
Stock Option (Right to Buy)
11.95
2018-08-09
4
M
0
363
0.00
D
2027-01-31
Common Stock
363
104569
D
Stock Option (Right to Buy)
11.95
2018-09-04
4
M
0
364
0.00
D
2027-01-31
Common Stock
364
104205
D
Stock Option (Right to Buy)
11.95
2018-10-01
4
M
0
364
0.00
D
2027-01-31
Common Stock
364
103841
D
Stock Option (Right to Buy)
11.95
2018-10-11
4
M
0
2500
0.00
D
2027-01-31
Common Stock
2500
101341
D
Stock Option (Right to Buy)
11.95
2018-11-06
4
M
0
364
0.00
D
2027-01-31
Common Stock
364
100977
D
Stock Option (Right to Buy)
11.95
2018-12-03
4
M
0
364
0.00
D
2027-01-31
Common Stock
364
100613
D
Stock Option (Right to Buy)
11.95
2019-02-25
4
M
0
3000
0.00
D
2018-06-28
2027-01-31
Common Stock
3000
3250
D
25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
On February 1, 2017, the Reporting Person was granted an option to purchase 25,000 shares of Common Stock under the issuer's 2015 Equity Incentive Plan, the vesting of which was subject to various conditions (other than the passage of time and continued employment) that were not tied to the market price of the issuer's securities. On June 28, 2018, one of the conditions was deemed to be achieved, resulting in the vesting and exercisability of 6,250 of the shares underlying such option.
/s/ Cynthia J. Ladd, as Attorney-in-Fact
2019-10-29